University, Subject, Country, Region, World
The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings, University Subject Rankings and Universities Rankings 2024 (Sort by: Last 6 years H Index). Click here for individual or institutional registration.
| AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
| 172 | 147,674 | 166,601 | 523,620 |
|
 United States
|
Pfizer Inc.
|
Economics & Econometrics / Economics
Economics | pharmaceutical sciences | outcomes research | |
18 | 14 | 0.778 | 23 | 18 | 0.783 | 2,951 | 1,323 | 0.448 |
| 209 | 171,892 | 193,566 | 621,260 |
|
United States
|
Pfizer Inc.
|
Economics & Econometrics / Economics
Health Economics and Outcomes Research | Health Technology Assessment | COVID-19 | Cost-effectiveness | Budget Impact | |
15 | 15 | 1.000 | 20 | 20 | 1.000 | 803 | 798 | 0.994 |
| 210 | 173,590 | 195,398 | 627,703 |
|
United States
|
Pfizer Inc.
|
Economics & Econometrics / Economics
health economics | |
15 | 14 | 0.933 | 21 | 21 | 1.000 | 608 | 506 | 0.832 |
| 344 | 242,831 | 271,856 | 922,107 |
|
United States
|
Pfizer Inc.
|
Economics & Econometrics / Economics
Economics | Economic Development | Health policy | |
10 | 6 | 0.600 | 11 | 6 | 0.545 | 1,848 | 591 | 0.320 |
| 370 | 257,114 | 287,629 | 988,792 |
|
United States
|
Pfizer Inc.
|
Economics & Econometrics / Economics
Valuation Assessment | Research Studies: Patient Health Outcomes/Economics/Health Policy | |
9 | 5 | 0.556 | 9 | 5 | 0.556 | 555 | 283 | 0.510 |